pefloxacin has been researched along with Disease Models, Animal in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Iudin, SM; Lobuseva, AN | 1 |
| D'iakov, SI; Katsalukha, VV; Lebedeva, IK; Lukashina, AV; Raĭskaia, VA | 1 |
| Anastassiadou, H; Dassiou, M; Samonis, G | 1 |
| Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
| Merta, M; Nĕmecek, K; Poledne, R; Rychlík, I; Stípek, S; Tĕmínová, J; Tesar, V; Zima, T | 1 |
| Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Gras, C; Jehl, F; Kergueris, MF; Le Conte, P; Navas, D; Potel, G; Xiong, YQ | 1 |
| Bernard, E; Carsenti-Etesse, H; Dellamonica, P; Durant, J; Entenza, J; Mondain, V; Pradier, C | 1 |
| Glukhova, EV; Shenderov, BA; Viadro, MM | 1 |
| Mnatsakanian, VE; Padeĭskaia, EN | 1 |
| Dworkin, R; Kunz, S; Modin, G; Rich, R; Sande, M; Zak, O | 1 |
| Barzilai, A; Keren, G; Leibovitz, E; Rubinstein, E; Shabtai, M | 1 |
| Edlund, C; Lahnborg, G; Nord, CE | 1 |
| Ritzerfeld, W | 1 |
14 other study(ies) available for pefloxacin and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
[Chemotherapeutic effectiveness of pefloxacin in experimental infections].
Topics: Acute Disease; Administration, Oral; Animals; Disease Models, Animal; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Pefloxacin; Peritonitis; Pneumonia; Sepsis | 1994 |
[Comparative evaluation of the effectiveness of fluoroquinolones in experimental anthrax infection].
Topics: Animals; Anthrax; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Fluoroquinolones; Lethal Dose 50; Mice; Microbial Sensitivity Tests; Pefloxacin; Quinolones | 1994 |
Antibiotics affecting gastrointestinal colonization of mice by yeasts.
Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefotaxime; Digestive System; Disease Models, Animal; Feces; Gastrointestinal Diseases; Male; Mice; Mice, Inbred ICR; Pefloxacin | 1994 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
The influence of pefloxacine on experimental adriamycin-induced nephrotic syndrome in rats.
Topics: Animals; Disease Models, Animal; Doxorubicin; Drug Evaluation, Preclinical; Female; Nephrotic Syndrome; Pefloxacin; Proteinuria; Rats; Rats, Wistar; Time Factors | 1996 |
Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Fosfomycin; Half-Life; Humans; Infusions, Intravenous; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation; Treatment Outcome | 1997 |
Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice.
Topics: Animals; Bacterial Adhesion; Disease Models, Animal; Female; Foreign Bodies; Mice; Pefloxacin; Peritoneal Cavity; Spleen; Staphylococcal Infections; Staphylococcus aureus | 1992 |
[Microbial ecology of laboratory animals as a model in evaluation of the immunomodulating and antimicrobial agents].
Topics: Adjuvants, Immunologic; Animals; Bacillus; Bacterial Adhesion; Bacterial Infections; Colitis; Colon; Cyclophosphamide; Disease Models, Animal; Models, Biological; Neutropenia; Pefloxacin; Polysaccharides, Bacterial; Rats; Rats, Wistar | 1992 |
[Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Enoxacin; Meningoencephalitis; Mice; Ofloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 1991 |
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
Topics: Animals; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Male; Methicillin; Osteomyelitis; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1990 |
The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
Topics: Abscess; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Enterobacteriaceae Infections; Female; Fleroxacin; Half-Life; Pefloxacin; Rats; Serratia marcescens | 1989 |
The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clostridium perfringens; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Male; Metronidazole; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Proteus mirabilis; Rats; Rats, Inbred Strains | 1986 |
Efficacy of pefloxacin in experimental Pseudomonas aeruginosa pyelonephritis.
Topics: Animals; Disease Models, Animal; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rats | 1987 |